Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alicaforsen enema in mild to moderate active ulcerative colitis
NCT00063414Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Nov 2002
- Primary completion
- Mar 2005
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alicaforsen in ulcerative colitis (UC) (3 arms), sponsored by Ionis Pharmaceuticals. Primary endpoint: Percentage reduction in Disease Activity Index at 6 weeks. Started Nov 2002; status: completed.
02
Drugs
alicaforsen
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00063414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063414.